R C M Technologies Inc

R C M Technologies Inc(RCMT)股票分析

$34.890

+0.031 (+0.09%)收盘时

Loading chart…
最高
35.615
开盘
35.330
成交量加权均价
35.07
成交量
43.35K
市值
142.82M
最低
34.705
成交额
1.52M
企业价值/息税折旧摊销前利润(TTM)
7.14

RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals.

AI 分析 of R C M Technologies Inc (RCMT)

持有

RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.

分析师评级(1)

-8.28% 下跌空间
买入
1 买入
0 持有
0 卖出
当前: 34.89
最低
32.00
平均
32.00
最高
32.00

Benchmark

2026-04-08

目标价

$36

买入

Benchmark

2025-03-21

目标价

$30

强烈买入

Benchmark

2024-11-11

目标价

$37

强烈买入

B. Riley Securities

2024-11-11

目标价

$37

强烈买入

Benchmark

2024-08-13

目标价

$33

强烈买入

估值指标

R C M Technologies Inc(RCMT)当前预期市盈率为 16.18,5 年平均预期市盈率为 9.54。

预期市盈率

严重高估
5 年均值 P/E
9.54
当前P/E
16.18
高估
12.46
低估
6.63

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
6.38
当前EV/EBITDA
7.14
高估
7.79
低估
4.98

预期市销率

合理
5 年均值 P/S
0.53
当前P/S
0.64
高估
0.65
低估
0.40

Alphio AI 对 RCMT 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%RCMT

$26.08

情景价格

基

基准

基准 · 50%RCMT

$21.24

情景价格

悲

悲观

悲观 · 25%RCMT

$18.77

情景价格

事件时间线

2026-05-15 (ET)

13:20:00

RCM Technologies Q1 Earnings Decline, Shares Down Nearly 19%

2025-07-01 (ET)

08:44:35

RCM Technologies added to Russell 3000, small-cap Russell 2000 Indexes

2025-03-12 (ET)

16:16:59

RCM Technologies reports Q4 EPS 49c, vs. 73c last year

2025-02-25 (ET)

07:48:00

RCM Technologies launches RCM HCM's program to resell UKG Ready suite

2024-12-23 (ET)

07:30:05

Twelve option delistings on December 23rd

资讯

RCMT 常见问题 —— 由 Alphio AI 解答

RCM Technologies, Inc. is a provider of business and technology solutions through the deployment of specialty healthcare, engineering, life sciences, information technology services, data management and solutions. The Company's segments include Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The Specialty Health Care segment provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. The Engineering segment provides a comprehensive portfolio of engineering and design services across three verticals: energy services, process and industrial, and aerospace. The LS&D segment provides enterprise business solutions, application development and support, information technology infrastructure deployment and management, and technology and business solutions for the Life Sciences industry and other specific verticals. It operates in the Industrials sector (SERVICES-HELP SUPPLY SERVICES industry).

RCM Technologies Inc is currently a hold. The stock is priced at $34.99, which is 67.1% of its 52-week range, indicating it is closer to the high end. The RSI is at 21.62, suggesting it is oversold, but the recent 20-day change of -15.87% indicates a downward trend. Additionally, the forward P/E of 12.80 suggests it is undervalued compared to its earnings potential, but the upcoming earnings report on November 4 could be a risk factor if results do not meet expectations.

1 analysts cover RCMT: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 32.00.

暂无帖子

注册或登录后参与讨论

相关文章

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易